Over the past decade, drug makers have settled patent litigation by making large payments to potential rivals who, in …

look at the development that has taken place in other jurisdictions and adapt the patent law to local conditions when …

Patent settlements between originator and generic firms in the pharmaceutical industry have been challenged by … entry and therefore harming consumers. However, it is still heavily disputed under what conditions such patent settlements … contributed to our knowledge about the effects of these patent settlements and the possible rules for their antitrust treatment …

witnessed by the fact that patent applications are very skewed in the covered trade names and patent thickness expands over time … pharmaceutical firms, between patent portfolio and profit margins. …